the results of two therapeutic trials in female patients with uncomplicated urogenital gonorrhoea ( a ) and in male patients with uncomplicated urethral gonorrhoea ( b ) treated with either 200 mg and 400 mg enoxacin orally , of one therapeutic trial in male patients with uncomplicated urogenital gonorrhoea treated with either 250 mg or 500 mg ciprofloxacin orally ( c ) and of one therapeutic trial in male patients with non-gonococcal urethritis ( ngu ) treated with ciprofloxacin 1 g daily during seven days ( d ) are presented and compared with the results of other investigators .
C0018081
gonorrhoea
C0008809
ciprofloxacin